MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTOR™. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus.
The Stop TB Partnership’s Global Drug Facility and UNITAID announced a collaboration with 19 countries to address life-threatening shortages of anti-tuberculosis drugs.
A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the Oct. 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
In this retrospective cohort study that included 852 primary care physicians in Quebec, international medical graduates, physicians with high practice volumes and those who were in practice longer were more likely to prescribe antibiotics inappropriately.
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest University School of Medicine and colleagues. When the drugs are taken with aspirin and other similar pain medications, the risk is more than 600 percent higher.
High-risk teenagers who participate in peer-led substance abuse prevention programs reduce their drug use by approximately 15 percent versus traditional curricula, suggests a study led by researchers at the University of Southern California (USC).
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects – and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.
GlaxoSmithKline and Anacor Pharmaceuticals announced that they have entered into a worldwide strategic alliance for the discovery, development and commercialisation of novel medicines for viral and bacterial diseases. The collaboration provides GlaxoSmithKline access to Anacor’s proprietary boron-based chemistry for use against selected targets.
The Centers for Medicare & Medicaid Services (CMS) announced that the agency will collect $4 billion from Part D drug plan sponsors due to lower-than-expected drug costs in 2006, the first year of the Medicare drug program. This collection results from the payment reconciliation that CMS has completed for 2006, including the application of risk sharing created under the Medicare Modernization Act (MMA).
Current food labeling leads to under-consumption of calcium, according to this study. Those who were taught how to translate the information consumed more. Researchers believe the same is true for other beneficial nutrients.